View original publication
- There is fair evidence to support screening and treatment of pregnant women during the first trimester as well as annual screening and treatment of high risk groups (sexually active women less than 25 years of age, men or women with new or multiple sexual partners during the preceding year, women who use nonbarrier contraceptive methods and women who have symptoms of chlamydial infection: cervical friability, mucopurulent cervical discharge or intermenstrual bleeding.
(grade B recommendation)
- There is fair evidence to exclude routine screening of the general population.
(grade D recommendation)